NCT06538792 Proprioception, Muscle Strength and Kinesiophobia After Anterior Cruciate Ligament Reconstruction
| NCT ID | NCT06538792 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bezmialem Vakif University |
| Condition | Anterior Cruciate Ligament Reconstruction |
| Study Type | OBSERVATIONAL |
| Enrollment | 52 participants |
| Start Date | 2024-11-09 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 52 participants in total. It began in 2024-11-09 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fear of re-injury after anterior cruciate ligament reconstruction surgery (ACLR) affects individuals' return to sports and physical activity negatively. The aim of this study is to evaluate the effects of proprioception and muscle strength on kinesiophobia in patients who have undergone anterior cruciate ligament reconstruction surgery.
Eligibility Criteria
Inclusion Criteria: * Between the ages of 18-35 * History of ACL reconstruction surgery at least 6 months ago Exclusion Criteria: * History of previous lower extremity surgery * History of lower extremity injury within the last 6 months * Having a vestibular or neurologic pathology that would affect balance
Contact & Investigator
Kubra Alpay, PhD
PRINCIPAL INVESTIGATOR
Bezmialem Vakif University
Frequently Asked Questions
Who can join the NCT06538792 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Anterior Cruciate Ligament Reconstruction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06538792 currently recruiting?
Yes, NCT06538792 is actively recruiting participants. Contact the research team at kubraalpay@hotmail.com for enrollment information.
Where is the NCT06538792 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT06538792 clinical trial?
NCT06538792 is sponsored by Bezmialem Vakif University. The principal investigator is Kubra Alpay, PhD at Bezmialem Vakif University. The trial plans to enroll 52 participants.